Get the app!
Back to Trades

Siegrist Jonathan Philip

EVP of R&D & CTOCIK 0002040321

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
3
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Siegrist Jonathan Philip, EVP of R&D & CTO, accounts for 3 disclosed filings worth $1.2M, all concentrated in QuidelOrtho Corp (QDEL), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
Feb 3QDEL
QuidelOrtho Corp
Siegrist Jonathan PhilipEVP of R&D & CTOAward$982.2K
Feb 2QDEL
QuidelOrtho Corp
Siegrist Jonathan PhilipEVP of R&D & CTOGrant$27.7K
Oct 17QDEL
QuidelOrtho Corp
Siegrist Jonathan PhilipEVP of R&D & CTOGrant$182.3K

3 filings